Psoriasis is a hyperproliferative inflammatory disease that is considered to be involved with both gene and environmental factors, such as stress. Serotonin plays an important role related to stress, and thus, can be a candidate for relieving disease symptoms. We investigated the expression of the serotonin gene receptor ofthe 5-HT3AR subtype on mononuclear blood cells in psoriatic patients as compared to healthy individuals. We isolated Peripheral Mononuclear Cells (PBMCs) from blood samples followed by total cellular RNA extraction, cDNA synthesis, and real-time PCR using primer pairs specific for 5-HT3AR mRNA and beta-actin mRNA as an internal control. Finally RT-PCR products were sequenced. Results showed that the expression of 5-HT3AR was significantly reduced (P<O.OOl) in patients compared to the healthy individuals group. However, there were no related nucleotide changes in the sequencing analysis of gene coding region. Our results raise the possibility of using 5-HT3A receptor specific drugs in the treatment of psoriasis.
Psoriasis is an autoimmune disease that affects approximately 2.5% of the global population (1). The disorder is characterized by an increase in proliferation and an altered maturation of epidermal cells (2) . Psoriasis can be triggered by several environmental factors, including stress or mood disorders (3, 4) . Since many skin disorders like psoriasis have been found to be controlled by the nervous system, neurotransmitters and neuropeptides such as VIP, acetylcholine, histamine, substance P, etc. have been shown to modulate psoriasis (5) .
Serotonin or 5-hydroxytryptamine (5-HT) plays a role as both a neurotransmitter and a neuromodulator, operating in brain and peripheral tissues, which are upregulated by stress. It is also a vasoactive amine, released by platelets at sites of inflammation (6) .
Serotonin mediates a wide variety of behavioral and physiological functions by its two subgroups of receptors: G-protein coupled receptors and ligandgated ion channels. Five-HT3 Receptor (5-HT3R) is the only ligand-gated ion channel receptor and is a pentameric, with the possibility of conversion to homomeric or heteromeric combination of different subunits (A, B, C, D and E). The most efficient one is a subunit A homopentameric receptor. This subtype (5-HT3AR) is expressed on both neurons and lymphocytes (7, 8) . On lymphocyte surfaces, an inflammatory role is suggested for this receptor via the activation of lymphocytic cells (9). Nordlind et al. determined that expression of 5-HT3R could be found in the basal epidermal layer of non-involved cells but not in the skin involved in psoriasis (l 0).
In order to study the pathophysiological role of serotonin in psoriasis, we performed real time reverse transcriptase quantitative PCR by SYBR Green to investigate 5-HT3AR gene expression on PBMCs of patients with psoriasis in comparison with a non-psoriatic, healthy group. Moreover, gene coding of 5-HT3AR was sequenced in all samples.
MATERIALS AND METHODS
Thirty patients with psoriasis vulgaris, admitted to the Clinic of Dermatology of Razi Hospital of Tehran, Iran, were enrolled in the study. Four milliliters (mL) of peripheral blood samples were taken from each patient, 15 of whom were male and 15 female. The patient population had a mean age of 34 years and ranged in age from 20 to 40 years. Samples were also taken from 30 healthy subjects, 15 of whom were male and 15 female. The healthy group had a mean age of 26 years, where ages ranged from 20 to 35 years. Healthy participants were excluded if they had been diagnosed with inflammatory dermatosis, asthma, allergy, or any kind of psychiatric disorder or mental illness.
All clinical procedures were approved by the local ethics committee of Razi Hospital. All participants gave their informed consent prior to their inclusion in the study.
PBMCs from collected samples were isolated using density gradient centrifuge by Ficoll Hypaque (Lymphoperp TM, Oslo, Norway). The buffy coat layer was removed and washed twice with sterile phosphate buffer saline (PBS), resulting in a final count of 10-6 to 3x I0-6 cells for total RNA extraction.
Total RNA of the PBMCs was extracted using High pure RNA isolation kit (Roche, Germany) according to the manufacturer's instructions. Extracted samples were preserved long-term at -70°C. RNA (5 ug) from each sample was used to synthesize first-strand cDNA according to the manufacturer protocol (Fermentas, USA).
To confirm existing total RNA in the samples and to verify previous steps, we continued by conventional PCR, using Beta-actin primer sets (II). PCR cycles used TECHNE Flexigene (Techne Flexigen, Minneapolis, MN, USA). PCR products were separated using 2% agarose gel electrophoresis supplemented with ethidium bromide for DNA product visualization under UV light.
After verifying RNA extraction, the product was amplified using RT-PCR with primer sets specific for 5-HT3AR and Beta-actin as an internal control (Table I) . Whole mRNA of5-HT3AR was separated into 4 segments using 4 different primer pairs. The comparison of each segment further confirmed the success of previous steps. Beta-actin and 5-HT3AR transcripts were quantified in samples using LightCycler ver. 2 (Roche, Germany) and light cycler fast start DNA master plus SYBR green I kit (Roche, Germany). Real time-PCR experiments were performed in triplicate per individual to avoid artificial bias.
PCR products of serotonin receptor 5-HT3A were sequenced by DNA sequencer ABI 3700 capillary system (Applied Biosystem, USA) to confirm amplicon sequence and structural changes at RNA level.
The statistical significance between the two groups was tested using independent sample test analysis of variance for the output of LightCycler. All analyses were carried out using the SPSS 16.0 (SPSS, Inc, Chicago, IL). Relative mRNA expression was calculated by the 880method (12) . The probability value of this study was less than 0.001 (P <0.001).
RESULTS
Weexamined the change in expression ofserotonin receptor subtype 5-HT3AR by a highly sensitive method of real-time PCR. The amplicon sequence and size was corroborated using gel electrophoresis and sequencing. Fig. I shows the results of gel electrophoresis of 5-HT3AR gene fragments, and related exon sequence s of fragment 3; Fig. 2 shows fragment 3's adaptation with its sequence in NCBI.
Finally, we sequenced all the mRNA in order to screen for any mutations. However, sequence analysis of PCR products showed no nucleotide changes . Nevertheless , the express ion of the 4 fragment s of 5-HT3AR mRNA normalized to beta-actin expression was analyzed by real time PCR. Table II shows Mean and Standard deviation for 5HT3AR gene expression. Statistical analysis was performed using Levene's test to survey the equality ofvariances and 2-tail r-test to validate this expression change (Table III ). The p-value of the examination was less than 0.001. As shown in Fig. 3 , the expression of the studied gene in the psoriatic group in comparison with the non-psoriat ic group is significantly decreased. By using 88Ct-method (12) we estimate that psoriasis decrea ses the expression of5-HT3AR gene by 0.027fold normalized to Beta-actin gene expression and in relation to non-psoriatic individuals. As a result, the expression of 5-HT3AR on PBMCs of psoriatic patients significantly decreases (p<O.OO1).
DISCUSSION
Due to the important role of lymphocyte s in psoriasis (13) , the presence of serotonin receptors on these cells suggests the possibility of modulating serotonin to relieve the symptoms of this disorder. As Maurer et al. reported, serotonin stimulat es proliferation of keratinocytes (14) . This finding confirms our study result showing that the level of serotonin in psoriatic lesions increases ( IS). There is evidence that shows the activation of blood platelets in patients with psoriasis (16) , and release of serotonin by these activated platelets (17) ; in other words, serum level of serotonin also (18) . By using serotonergic receptor antagonists, scientists have determined that 5-HT3R plays a role in lymphocyte activation (9) . Thus, we focused on this receptor's expression changes in lymphocytes of psoriatic patients. The 5-HT3AR subtype of this receptor is the most important subtype because it is the only subtype with the necessary signal peptide which helps pentameric receptors appear on the cell surface. Additionally, the 5-HT3R ligand binding site is located on A subunit (19) .
With regards to neouroimmunoendocrinology, a discipline concerning the interactions between neural, immune and endocrine system, there have been many studies that survey the effects of neurotransmitters on autoimmune disorders (20) . Shariati et al. have shown decreasing expression of 5-HT3AR gene in schizophrenia (11). In addition, researchers in the field of psoriasis recently evaluated a number of studies to show the effects of neurotransmitters and neuropeptides on psoriasis (5, 21) . In this study we used real time reverse transcriptase quantitative PCR by SYBR Green and showed that the expression of serotonin receptor subtype 5-HT3AR is decreased in patients suffering from psoriasis. There have been no results regarding the 5-HT3AR amplicon sequence and structural changes at RNA level related to the psoriasis. Nor does our study show any changes in this region. This is in line with a possible downregulation of 5-HT3 receptor. Serotonin level increases, in relation to stress, and can trigger many disorders such as psoriasis. In order to normalize the disregulation, the body tries to relieve the expression of serotonin receptor. In this way we can help the body to cure the disease by using 5-HT3 receptor inhibitors as a drug.
Based on our results, for further studies we can suggest, surveying the probable effects of 5-HT3R antagonists on psoriasis patients to find a new treatment.
